Trials / Withdrawn
WithdrawnNCT04274790
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
Analysis of the Impact of 5-Fluorouracil on the Translational Control and Plasticity of Cancer Cells From Liver Metastases of Colon Cancer
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Centre Leon Berard · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Analyze the dynamics of incorporation of 5-fluorouracil into cancer cell ribosomes from liver metastases of patient with metastatic colon cancer.
Detailed description
This is a monocentric, prospective, non-interventional cohort study in adult patients with metastatic colon cancer with hepatics metastasis. Tumour samples collected for this study include: * A fragment of the previously operated primary tumor: FFIP block and/or archived frozen tumor if available. * A fragment of the liver metastasis(s) performed as part of standard metastasis surgery, this fragment will include a tumor area and a healthy area within the margin of excision. These samples collected in a fresh state will be analyzed immediately.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Scheduled and planned surgery | Collection of tumour samples from samples collected as part of standard patient management. Diagnostic pathological analysis will be a priority. These samples will be taken by experienced staff during the hospital visit scheduled as part of standard care. |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2020-02-18
- Last updated
- 2024-02-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04274790. Inclusion in this directory is not an endorsement.